Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Pioglitazone in Alzheimer Disease

This study has been completed.
Takeda Pharmaceuticals North America, Inc.
Information provided by:
National Institute on Aging (NIA) Identifier:
First received: September 22, 2009
Last updated: NA
Last verified: September 2009
History: No changes posted
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: January 2005
  Primary Completion Date: January 2005 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by Identifier (NCT Number):